IL108139A0 - Pharmaceutical compositions containing folic acid analogues and protecting agents - Google Patents

Pharmaceutical compositions containing folic acid analogues and protecting agents

Info

Publication number
IL108139A0
IL108139A0 IL10813993A IL10813993A IL108139A0 IL 108139 A0 IL108139 A0 IL 108139A0 IL 10813993 A IL10813993 A IL 10813993A IL 10813993 A IL10813993 A IL 10813993A IL 108139 A0 IL108139 A0 IL 108139A0
Authority
IL
Israel
Prior art keywords
folic acid
pharmaceutical compositions
compositions containing
acid analogues
protecting agents
Prior art date
Application number
IL10813993A
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL108139A0 publication Critical patent/IL108139A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL10813993A 1992-12-23 1993-12-22 Pharmaceutical compositions containing folic acid analogues and protecting agents IL108139A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929226842A GB9226842D0 (en) 1992-12-23 1992-12-23 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
IL108139A0 true IL108139A0 (en) 1994-04-12

Family

ID=10727128

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10813993A IL108139A0 (en) 1992-12-23 1993-12-22 Pharmaceutical compositions containing folic acid analogues and protecting agents

Country Status (15)

Country Link
US (3) US6358952B1 (fr)
EP (1) EP0675719B1 (fr)
JP (1) JP3774850B2 (fr)
KR (1) KR100296643B1 (fr)
AT (1) ATE167058T1 (fr)
AU (1) AU676252B2 (fr)
CA (1) CA2152507C (fr)
DE (1) DE69319141T2 (fr)
ES (1) ES2117245T3 (fr)
GB (1) GB9226842D0 (fr)
IL (1) IL108139A0 (fr)
MX (1) MX9400215A (fr)
TW (1) TW340044B (fr)
WO (1) WO1994014448A1 (fr)
ZA (1) ZA939633B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6762188B1 (en) 1990-06-19 2004-07-13 Smithkline Beecham Corporation Pharmaceutically active benzoquinazoline compounds
GB9226842D0 (en) * 1992-12-23 1993-02-17 Wellcome Found Pharmaceutical compounds
DE10062401A1 (de) * 2000-12-14 2002-06-20 Beiersdorf Ag Verwendung von Folsäure und/oder deren Derivaten zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe von Schäden an der hauteigenen DNA und/oder zur Reparatur bereits eingetretener Schäden an der hauteigenen DNA
US7547964B2 (en) * 2005-04-25 2009-06-16 International Rectifier Corporation Device packages having a III-nitride based power semiconductor device
US8501242B2 (en) * 2009-05-29 2013-08-06 University Of Florida Research Foundation Methods and compositions for treating neoplasia
CN101580501B (zh) 2009-06-01 2011-03-09 南京卡文迪许生物工程技术有限公司 3-(取代二氢异吲哚酮-2-基)-2,6-哌啶二酮的合成方法及其中间体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
US5217974A (en) 1991-03-29 1993-06-08 Eli Lilly And Company Method for treating gar-transformylase tumors in mammals and reducing mammalian toxicity
AU640524B2 (en) * 1991-03-29 1993-08-26 Eli Lilly And Company Use of folic acid for reducing the toxicity of antitumour antifolate agents and methods for treating tumours
GB9119700D0 (en) 1991-09-14 1991-10-30 Int Computers Ltd Cryptographic facility for a data processing system
GB9226842D0 (en) * 1992-12-23 1993-02-17 Wellcome Found Pharmaceutical compounds

Also Published As

Publication number Publication date
KR100296643B1 (ko) 2001-10-22
EP0675719B1 (fr) 1998-06-10
WO1994014448A1 (fr) 1994-07-07
KR950703963A (ko) 1995-11-17
JP3774850B2 (ja) 2006-05-17
US6358952B1 (en) 2002-03-19
AU5708494A (en) 1994-07-19
US6579877B2 (en) 2003-06-17
ES2117245T3 (es) 1998-08-01
US20030203924A1 (en) 2003-10-30
GB9226842D0 (en) 1993-02-17
DE69319141D1 (de) 1998-07-16
US6855712B2 (en) 2005-02-15
ZA939633B (en) 1995-06-22
AU676252B2 (en) 1997-03-06
MX9400215A (es) 1994-07-29
US20020137748A1 (en) 2002-09-26
JPH08504800A (ja) 1996-05-28
ATE167058T1 (de) 1998-06-15
CA2152507C (fr) 2005-10-18
TW340044B (en) 1998-09-11
EP0675719A1 (fr) 1995-10-11
DE69319141T2 (de) 1998-10-08
CA2152507A1 (fr) 1994-07-07

Similar Documents

Publication Publication Date Title
IL101145A0 (en) Pharmaceutical compositions containing synergistic combinations of nucleoside derivatives
EP0497258A3 (en) Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer
HUT67398A (en) 1h-imidazo(4,5-c)quinolin-4-amin derivatives, pharmaceutical compositions containing them
AU576563B2 (en) Pyridazine derivatives
EP0783299A4 (fr) Composes et compositions pour l'administration d'agents actifs
CA2058428A1 (fr) Formulations analgesiques
ZA928771B (en) Combination chemotherapy
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
NO944113L (no) Stabilt, hydratisert cefalosporin-tört pulver for oral suspensjonsformulering
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
IE873125L (en) Benzimidazole derivatives
EP0620004A4 (fr) Compositions medicinales.
IL108139A0 (en) Pharmaceutical compositions containing folic acid analogues and protecting agents
HUT67287A (en) Piperazynil camphor derivatives and pharmaceutical compositions containing them
CZ123595A3 (en) The use of xanthine derivatives for preparing pharmaceutical preparations and pharmaceutical compositions containing said derivatives
ES8504774A1 (es) Procedimiento para preparar derivados de 2-piperacinil-quinazolina
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
ZA947401B (en) Use of partially methylated beta-cyclodextrins as absorption promoters in the preparation of pharmaceutical compositions for the transcutaneous administration of active principles
TR199900141T2 (xx) Bunama tedavisi ve/veya profilaksisi i�in form�lasyon.
ATE102934T1 (de) Fluorierte flavon-essigsaeure.
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)